Literature DB >> 27084183

Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.

Marco Falcone1, Ercole Concia2, Massimo Giusti3, Antonino Mazzone4, Claudio Santini5, Stefania Stefani6, Francesco Violi7.   

Abstract

Skin and soft tissue infections (SSTIs) are a common cause of hospital admission among elderly patients, and traditionally have been divided into complicated and uncomplicated SSTIs. In 2010, the FDA provided a new classification of these infections, and a new category of disease, named acute bacterial skin and skin structure infections (ABSSSIs), has been proposed as an independent clinical entity. ABSSSIs include three entities: cellulitis and erysipelas, wound infections, and major cutaneous abscesses This paper revises the epidemiology of SSTIs and ABSSSIs with regard to etiologies, diagnostic techniques, and clinical presentation in the hospital settings. Particular attention is owed to frail patients with multiple comorbidities and underlying significant disease states, hospitalized on internal medicine wards or residing in nursing homes, who appear to be at increased risk of infection due to multi-drug resistant pathogens and treatment failures. Management of ABSSSIs and SSTIs, including evaluation of the hemodynamic state, surgical intervention and treatment with appropriate antibiotic therapy are extensively discussed.

Entities:  

Keywords:  Acute bacterial skin and skin structure infections; Elderly patients; Internal medicine wards; New drugs

Mesh:

Substances:

Year:  2016        PMID: 27084183     DOI: 10.1007/s11739-016-1450-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  50 in total

1.  Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study.

Authors:  Alessandro Nobili; Alessandra Marengoni; Mauro Tettamanti; Francesco Salerno; Luca Pasina; Carlotta Franchi; Alfonso Iorio; Maura Marcucci; Salvatore Corrao; Giuseppe Licata; Pier Mannuccio Mannucci
Journal:  Eur J Intern Med       Date:  2011-09-29       Impact factor: 4.487

Review 2.  Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.

Authors:  Amilcar F Cardona; Samuel E Wilson
Journal:  Clin Infect Dis       Date:  2015-09-15       Impact factor: 9.079

3.  Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.

Authors:  Alessandro Nobili; Giuseppe Licata; Francesco Salerno; Luca Pasina; Mauro Tettamanti; Carlotta Franchi; Luigi De Vittorio; Alessandra Marengoni; Salvatore Corrao; Alfonso Iorio; Maura Marcucci; Pier Mannuccio Mannucci
Journal:  Eur J Clin Pharmacol       Date:  2011-01-11       Impact factor: 2.953

4.  Resource use in patients hospitalized with complicated skin and soft tissue infections in Europe and analysis of vulnerable groups: the REACH study.

Authors:  Helmut Ostermann; Francesco Blasi; Jesús Medina; Esther Pascual; Kyle McBride; Javier Garau
Journal:  J Med Econ       Date:  2014-07-25       Impact factor: 2.448

5.  Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.

Authors:  Christian Eckmann; Wendy Lawson; Dilip Nathwani; Caitlyn T Solem; Jennifer M Stephens; Cynthia Macahilig; Damien Simoneau; Petr Hajek; Claudie Charbonneau; Richard Chambers; Jim Z Li; Seema Haider
Journal:  Int J Antimicrob Agents       Date:  2014-05-16       Impact factor: 5.283

6.  A clinimetric evaluation of specialized geriatric care for rural dwelling, frail older people.

Authors:  K Rockwood; K Stadnyk; D Carver; K M MacPherson; H E Beanlands; C Powell; P Stolee; V S Thomas; R S Tonks
Journal:  J Am Geriatr Soc       Date:  2000-09       Impact factor: 5.562

7.  Vancomycin: we can't get there from here.

Authors:  Nimish Patel; Manjunath P Pai; Keith A Rodvold; Ben Lomaestro; George L Drusano; Thomas P Lodise
Journal:  Clin Infect Dis       Date:  2011-04-15       Impact factor: 9.079

8.  Single-dose oritavancin in the treatment of acute bacterial skin infections.

Authors:  G Ralph Corey; Heidi Kabler; Purvi Mehra; Sandeep Gupta; J Scott Overcash; Ashwin Porwal; Philip Giordano; Christopher Lucasti; Antonio Perez; Samantha Good; Hai Jiang; Greg Moeck; William O'Riordan
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

Review 9.  Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic.

Authors:  Marianne Billeter; Marcus J Zervos; Anne Y Chen; Joseph R Dalovisio; Changa Kurukularatne
Journal:  Clin Infect Dis       Date:  2008-02-15       Impact factor: 9.079

10.  Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department setting.

Authors:  Michael Quirke; Abel Wakai
Journal:  Int J Emerg Med       Date:  2015-04-22
View more
  10 in total

Review 1.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

2.  Identifying patients with acute bacterial skin and skin structure infection who need blood cultures.

Authors:  Giusy Tiseo; Antonino Mazzone; Marco Falcone
Journal:  Intern Emerg Med       Date:  2019-01-01       Impact factor: 3.397

3.  Real-World Evidence of Efficacy and Safety of Levonadifloxacin (Oral and IV) in the Management of Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Findings of a Retrospective, Multi-Center Study.

Authors:  Kapil D Mehta; Jai B Sharma; Ashok Anand; Pavan K Reddy N; Pramod Kadam; Khokan Debnath; Sandeep Bhapkar; Bini M Thampi
Journal:  Cureus       Date:  2022-04-20

4.  What COVID-19 taught us: New opportunities and pathways from telemedicine and novel antiseptics in wound healing.

Authors:  Alessandro Scalise; Marco Falcone; Giampiero Avruscio; Enrico Brocco; Eugenio Ciacco; Aurora Parodi; Rolando Tasinato; Elia Ricci
Journal:  Int Wound J       Date:  2021-10-02       Impact factor: 3.099

5.  Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections.

Authors:  William O'Riordan; Courtney Tiffany; Nicole Scangarella-Oman; Caroline Perry; Mohammad Hossain; Teri Ashton; Etienne Dumont
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

6.  Omadacycline for Acute Bacterial Skin and Skin Structure Infections.

Authors:  Fredrick M Abrahamian; George Sakoulas; Evan Tzanis; Amy Manley; Judith Steenbergen; Anita F Das; Paul B Eckburg; Paul C McGovern
Journal:  Clin Infect Dis       Date:  2019-08-01       Impact factor: 9.079

7.  Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis.

Authors:  Shao-Huan Lan; Wei-Ting Lin; Shen-Peng Chang; Li-Chin Lu; Chien-Ming Chao; Chih-Cheng Lai; Jui-Hsiang Wang
Journal:  Antibiotics (Basel)       Date:  2019-09-04

8.  Anti-Inflammatory Activity of Miodesin™: Modulation of Inflammatory Markers and Epigenetic Evidence.

Authors:  Carlos Rocha Oliveira; Rodolfo Paula Vieira
Journal:  Oxid Med Cell Longev       Date:  2020-05-15       Impact factor: 6.543

9.  Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update.

Authors:  Giuseppe Balice; Claudio Passino; Maria Grazia Bongiorni; Luca Segreti; Alessandro Russo; Marianna Lastella; Giacomo Luci; Marco Falcone; Antonello Di Paolo
Journal:  Antibiotics (Basel)       Date:  2022-07-07

10.  Simple and Accurate HPTLC-Densitometric Method for Quantification of Delafloxacin (A Novel Fluoroquinolone Antibiotic) in Plasma Samples: Application to Pharmacokinetic Study in Rats.

Authors:  Prawez Alam; Muzaffar Iqbal; Essam Ezzeldin; Nasr Y Khalil; Ahmed I Foudah; Mohammed H Alqarni; Faiyaz Shakeel
Journal:  Antibiotics (Basel)       Date:  2020-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.